(Circulation. 1996;94:2410-2416.)
© 1996 American Heart Association, Inc.
Articles |
the Division of Preventive Medicine (C.H.H.) and Channing Laboratory (J.M., M.J.S., W.C.W.), Departments of Medicine and Ambulatory Care and Prevention (C.H.H.), Brigham and Women's Hospital and Harvard Medical School, the Departments of Epidemiology (M.J.S., C.H.H.) and Nutrition (M.J.S., W.C.W.), Harvard School of Public Health, and the Jean Mayer USDA Human Nutrition Center on Aging at Tufts University (J.S.), Boston, Mass; the Oregon Regional Primate Research Center (M.R.M.), Beaverton, Ore; and the Departments of Human Genetics, Pediatrics, and Biology, McGill UniversityMontreal Children's Hospital Research Institute (P.F., J.H., R.R.), Montreal, Canada.
Background Hyperhomocysteinemia appears to be an independent risk factor for coronary disease. Elevated levels of plasma total homocysteine (tHCY) can result from genetic or nutrient-related disturbances in the transsulfuration or remethylation pathways for homocysteine metabolism. The enzyme 5,10-methylenetetrahydrofolate reductase (MTHFR) catalyzes the reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, the predominant circulatory form of folate, which serves as a methyl donor for remethylation of homocysteine to methionine. A common mutation in MTHFR recently has been identified.
Methods and Results We assessed the polymorphism in MTHFR, plasma tHCY, and folate using baseline blood levels among 293 Physicians' Health Study participants who developed myocardial infarction (MI) during up to 8 years of follow-up and 290 control subjects. The frequency of the three genotypes was (-/-) (homozygous normal), 47%; (+/-) (heterozygous), 41%; and (+/+) (homozygous mutant), 12%, with a similar distribution among both MI case patients and control subjects. Compared with those with genotype (-/-), the relative risk (RR) of MI among those with (+/-) was 1.1 (95% CI, 0.8 to 1.5), and it was 0.8 (0.5 to 1.4) for the (+/+) genotype; none of these RRs were statistically significant. However, those with genotype (+/+) had an increased mean tHCY level (mean±SEM, 12.6±0.5 nmol/mL), compared with those with genotype (-/-) (10.6±0.3) (P<.01). This difference was most marked among men with low folate levels (the lowest quartile distribution of the control subjects): those with genotype (+/+) had tHCY levels of 16.0±1.1 nmol/mL, compared with 12.3±0.6 nmol/mL (P<.001) for genotype (-/-).
Conclusions In this population, MTHFR polymorphism was associated with higher homocysteine levels but not with risk of MI. A gene-environment interaction might increase the risk by elevating tHCY, especially when folate intake is low.
Key Words: folate homocysteine myocardial infarction genetics epidemiology
This article has been cited by other articles:
![]() |
M. C. Reed, H. F. Nijhout, M. L. Neuhouser, J. F. Gregory III, B. Shane, S. J. James, A. Boynton, and C. M. Ulrich A Mathematical Model Gives Insights into Nutritional and Genetic Aspects of Folate-Mediated One-Carbon Metabolism J. Nutr., October 1, 2006; 136(10): 2653 - 2661. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E Chiuve, E. L Giovannucci, S. E Hankinson, D. J Hunter, M. J Stampfer, W. C Willett, and E. B Rimm Alcohol intake and methylenetetrahydrofolate reductase polymorphism modify the relation of folate intake to plasma homocysteine Am. J. Clinical Nutrition, July 1, 2005; 82(1): 155 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, M. D. Gammon, W. Chan, C. Palomeque, J. G. Wetmur, G. C. Kabat, S. L. Teitelbaum, J. A. Britton, M. B. Terry, A. I. Neugut, et al. One-Carbon Metabolism, MTHFR Polymorphisms, and Risk of Breast Cancer Cancer Res., February 15, 2005; 65(4): 1606 - 1614. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Smolkova, M. Dusinska, K. Raslova, M. Barancokova, A. Kazimirova, A. Horska, V. Spustova, and A. Collins Folate levels determine effect of antioxidant supplementation on micronuclei in subjects with cardiovascular risk Mutagenesis, November 1, 2004; 19(6): 469 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Garcia and K. Zanibbi Homocysteine and cognitive function in elderly people Can. Med. Assoc. J., October 12, 2004; 171(8): 897 - 904. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. V Dedoussis, D. B Panagiotakos, C. Chrysohoou, C. Pitsavos, A. Zampelas, D. Choumerianou, and C. Stefanadis Effect of interaction between adherence to a Mediterranean diet and the methylenetetrahydrofolate reductase 677C->T mutation on homocysteine concentrations in healthy adults: the ATTICA Study Am. J. Clinical Nutrition, October 1, 2004; 80(4): 849 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Cicek, N. L. Nock, L. Li, D. V. Conti, G. Casey, and J. S. Witte Relationship between Methylenetetrahydrofolate Reductase C677T and A1298C Genotypes and Haplotypes and Prostate Cancer Risk and Aggressiveness Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1331 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Terzolo, B. Allasino, S. Bosio, E. Brusa, F. Daffara, M. Ventura, E. Aroasio, G. Sacchetto, G. Reimondo, A. Angeli, et al. Hyperhomocysteinemia in Patients with Cushing's Syndrome J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3745 - 3751. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Curtin, J. Bigler, M. L. Slattery, B. Caan, J. D. Potter, and C. M. Ulrich MTHFR C677T and A1298C Polymorphisms: Diet, Estrogen, and Risk of Colon Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 285 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Voetsch and J. Loscalzo Genetic Determinants of Arterial Thrombosis Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 216 - 229. [Abstract] [Full Text] |
||||
![]() |
K.-J. Sohn, R. Croxford, Z. Yates, M. Lucock, and Y.-I. Kim Effect of the Methylenetetrahydrofolate Reductase C677T Polymorphism on Chemosensitivity of Colon and Breast Cancer Cells to 5-Fluorouracil and Methotrexate J Natl Cancer Inst, January 21, 2004; 96(2): 134 - 144. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Spotila, P. F. Jacques, P. B. Berger, K. V. Ballman, R. C. Ellison, and R. Rozen Age Dependence of the Influence of Methylenetetrahydrofolate Reductase Genotype on Plasma Homocysteine Level Am. J. Epidemiol., November 1, 2003; 158(9): 871 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. T. Russo, S. Friso, P. F. Jacques, G. Rogers, D. Cucinotta, P. W. F. Wilson, J. M. Ordovas, I. H. Rosenberg, and J. Selhub Age and Gender Affect the Relation between Methylenetetrahydrofolate Reductase C677T Genotype and Fasting Plasma Homocysteine Concentrations in the Framingham Offspring Study Cohort J. Nutr., November 1, 2003; 133(11): 3416 - 3421. [Abstract] [Full Text] [PDF] |
||||
![]() |
D M Levy, M P Massicotte, E Harvey, D Hebert, and E D Silverman Thromboembolism in paediatric lupus patients Lupus, October 1, 2003; 12(10): 741 - 746. [Abstract] [PDF] |
||||
![]() |
E. J. Jacobs, C. J. Connell, A. Chao, M. L. McCullough, C. Rodriguez, M. J. Thun, and E. E. Calle Multivitamin Use and Colorectal Cancer Incidence in a US Cohort: Does Timing Matter? Am. J. Epidemiol., October 1, 2003; 158(7): 621 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cattaneo Homocysteine and the Risk of Intrauterine Growth Retardation Clin. Chem., September 1, 2003; 49(9): 1432 - 1433. [Full Text] [PDF] |
||||
![]() |
Z. Li, L. Sun, H. Zhang, Y. Liao, D. Wang, B. Zhao, Z. Zhu, J. Zhao, A. Ma, Y. Han, et al. Elevated Plasma Homocysteine Was Associated With Hemorrhagic and Ischemic Stroke, but Methylenetetrahydrofolate Reductase Gene C677T Polymorphism Was a Risk Factor for Thrombotic Stroke: A Multicenter Case-Control Study in China Stroke, September 1, 2003; 34(9): 2085 - 2090. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kishi, J. Griener, C. Cheng, S. Das, E. H. Cook, D. Pei, M. Hudson, J. Rubnitz, J. T. Sandlund, C.-H. Pui, et al. Homocysteine, Pharmacogenetics, and Neurotoxicity in Children With Leukemia J. Clin. Oncol., August 15, 2003; 21(16): 3084 - 3091. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Martinelli, T. Battaglioli, P. Pedotti, M. Cattaneo, and P. M. Mannucci Hyperhomocysteinemia in cerebral vein thrombosis Blood, August 15, 2003; 102(4): 1363 - 1366. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Virdis, M. Iglarz, M. F. Neves, F. Amiri, R. M. Touyz, R. Rozen, and E. L. Schiffrin Effect of Hyperhomocystinemia and Hypertension on Endothelial Function in Methylenetetrahydrofolate Reductase-Deficient Mice Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1352 - 1357. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Inamoto, T. Katsuya, Y. Kokubo, T. Mannami, T. Asai, S. Baba, J. Ogata, H. Tomoike, and T. Ogihara Association of Methylenetetrahydrofolate Reductase Gene Polymorphism With Carotid Atherosclerosis Depending on Smoking Status in a Japanese General Population Stroke, July 1, 2003; 34(7): 1628 - 1633. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Ganji and M. R Kafai Demographic, health, lifestyle, and blood vitamin determinants of serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey, 1988-1994 Am. J. Clinical Nutrition, April 1, 2003; 77(4): 826 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Heijmans, J. M. A. Boer, H. E. D. Suchiman, C. J. Cornelisse, R. G. J. Westendorp, D. Kromhout, E. J. M. Feskens, and P. E. Slagboom A Common Variant of the Methylenetetrahydrofolate Reductase Gene (1p36) Is Associated with an Increased Risk of Cancer Cancer Res., March 15, 2003; 63(6): 1249 - 1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. de Bree, W. M. Verschuren, A.-L. Bjorke-Monsen, N. M. van der Put, S. G Heil, F. J. Trijbels, and H. J Blom Effect of the methylenetetrahydrofolate reductase 677C->T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample Am. J. Clinical Nutrition, March 1, 2003; 77(3): 687 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Crowther and J. G. Kelton Congenital Thrombophilic States Associated with Venous Thrombosis: A Qualitative Overview and Proposed Classification System Ann Intern Med, January 21, 2003; 138(2): 128 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Meleady, P. M Ueland, H. Blom, A. S Whitehead, H. Refsum, L. E Daly, S. E. Vollset, C. Donohue, B. Giesendorf, I. M Graham, et al. Thermolabile methylenetetrahydrofolate reductase, homocysteine, and cardiovascular disease risk: the European Concerted Action Project Am. J. Clinical Nutrition, January 1, 2003; 77(1): 63 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Rogers, A. Sanchez-Saffon, A. B. Frol, and R. Diaz-Arrastia Elevated Plasma Homocysteine Levels in Patients Treated With Levodopa: Association With Vascular Disease Arch Neurol, January 1, 2003; 60(1): 59 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Carmel, R. Green, D. S. Rosenblatt, and D. Watkins Update on Cobalamin, Folate, and Homocysteine Hematology, January 1, 2003; 2003(1): 62 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Carroll, D. Bhojwani, D.-J. Min, E. Raetz, M. Relling, S. Davies, J. R. Downing, C. L. Willman, and J. C. Reed Pediatric Acute Lymphoblastic Leukemia Hematology, January 1, 2003; 2003(1): 102 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Lim and P. A. Cassano Homocysteine and Blood Pressure in the Third National Health and Nutrition Examination Survey, 1988-1994 Am. J. Epidemiol., December 15, 2002; 156(12): 1105 - 1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L Ruberg and J. Loscalzo Prothrombotic determinants of coronary atherothrombosis Vascular Medicine, November 1, 2002; 7(4): 289 - 299. [Abstract] [PDF] |
||||
![]() |
M. M. de Jong, I. M. Nolte, G. J. te Meerman, W. T. A. van der Graaf, E. G. E. de Vries, R. H. Sijmons, R. M. W. Hofstra, and J. H. Kleibeuker Low-penetrance Genes and Their Involvement in Colorectal Cancer Susceptibility Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1332 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Burke, V. Fonseca, F. Kolodgie, A. Zieske, L. Fink, and R. Virmani Increased Serum Homocysteine and Sudden Death Resulting from Coronary Atherosclerosis With Fibrous Plaques Arterioscler. Thromb. Vasc. Biol., November 1, 2002; 22(11): 1936 - 1941. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Klerk, P. Verhoef, R. Clarke, H. J. Blom, F. J. Kok, E. G. Schouten, and and the MTHFR Studies Collaboration Group MTHFR 677C->T Polymorphism and Risk of Coronary Heart Disease: A Meta-analysis JAMA, October 23, 2002; 288(16): 2023 - 2031. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. McIlroy, K. B. Dynan, J. T. Lawson, C. C. Patterson, and A. P. Passmore Moderately Elevated Plasma Homocysteine, Methylenetetrahydrofolate Reductase Genotype, and Risk for Stroke, Vascular Dementia, and Alzheimer Disease in Northern Ireland Stroke, October 1, 2002; 33(10): 2351 - 2356. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Friso and S.-W. Choi Gene-Nutrient Interactions and DNA Methylation J. Nutr., August 1, 2002; 132(8): 2382S - 2387. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. N Ames, I. Elson-Schwab, and E. A Silver High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): relevance to genetic disease and polymorphisms Am. J. Clinical Nutrition, April 1, 2002; 75(4): 616 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Friso, S.-W. Choi, D. Girelli, J. B. Mason, G. G. Dolnikowski, P. J. Bagley, O. Olivieri, P. F. Jacques, I. H. Rosenberg, R. Corrocher, et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status PNAS, March 29, 2002; (2002) 62066299. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. P Fohr, R. Prinz-Langenohl, A. Bronstrup, A. M Bohlmann, H. Nau, H. K Berthold, and K. Pietrzik 5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women Am. J. Clinical Nutrition, February 1, 2002; 75(2): 275 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S Ford, S J. Smith, D. F Stroup, K. K Steinberg, P. W Mueller, and S. B Thacker Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies Int. J. Epidemiol., February 1, 2002; 31(1): 59 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Raife, S. R. Lentz, B. S. Atkinson, S. K. Vesely, and M. J. Hessner Factor V Leiden: a genetic risk factor for thrombotic microangiopathy in patients with normal von Willebrand factor-cleaving protease activity Blood, January 15, 2002; 99(2): 437 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.C. Verhaar, E. Stroes, and T.J. Rabelink Folates and Cardiovascular Disease Arterioscler. Thromb. Vasc. Biol., January 1, 2002; 22(1): 6 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Butler, A. D. Morris, and A. D. Struthers The T Allele of The C677T 5,10-Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphism May Protect Endothelial Function in Young, Normal Subjects Arterioscler. Thromb. Vasc. Biol., January 1, 2002; 22(1): 193 - 194. [Full Text] [PDF] |
||||
![]() |
P. Madonna, V. de Stefano, A. Coppola, F. Cirillo, A. M. Cerbone, G. Orefice, and G. Di Minno Hyperhomocysteinemia and Other Inherited Prothrombotic Conditions in Young Adults With a History of Ischemic Stroke Stroke, January 1, 2002; 33(1): 51 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Weger, O. Stanger, H. Deutschmann, M. Simon, W. Renner, O. Schmut, J. Semmelrock, and A. Haas Hyperhomocyst(e)inaemia, but not MTHFR C677T mutation, as a risk factor for non-arteritic ischaemic optic neuropathy Br. J. Ophthalmol., July 1, 2001; 85(7): 803 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Williams and P. F. Bray Genetics of Arterial Prothrombotic Risk States Experimental Biology and Medicine, May 1, 2001; 226(5): 409 - 419. [Abstract] [Full Text] |
||||
![]() |
M. Roest, Y. T. van der Schouw, D. E. Grobbee, M. J. Tempelman, P. G. de Groot, J. J. Sixma, and J. D. Banga Methylenetetrahydrofolate Reductase 677 C/T Genotype and Cardiovascular Disease Mortality in Postmenopausal Women Am. J. Epidemiol., April 1, 2001; 153(7): 673 - 679. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Q. Hanson, O. Aras, F. Yang, and M. Y. Tsai C677T and A1298C Polymorphisms of the Methylenetetrahydrofolate Reductase Gene: Incidence and Effect of Combined Genotypes on Plasma Fasting and Post-Methionine Load Homocysteine in Vascular Disease Clin. Chem., April 1, 2001; 47(4): 661 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Chen, A. C. Karaplis, S. L. Ackerman, I. P. Pogribny, S. Melnyk, S. Lussier-Cacan, M. F. Chen, A. Pai, S. W.M. John, R. S. Smith, et al. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition Hum. Mol. Genet., March 1, 2001; 10(5): 433 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Hines, M. J. Stampfer, J. Ma, J. M. Gaziano, P. M. Ridker, S. E. Hankinson, F. Sacks, E. B. Rimm, and D. J. Hunter Genetic Variation in Alcohol Dehydrogenase and the Beneficial Effect of Moderate Alcohol Consumption on Myocardial Infarction N. Engl. J. Med., February 22, 2001; 344(8): 549 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. Saw, J.-M. Yuan, C.-N. Ong, K. Arakawa, H.-P. Lee, G. A Coetzee, and M. C Yu Genetic, dietary, and other lifestyle determinants of plasma homocysteine concentrations in middle-aged and older Chinese men and women in Singapore Am. J. Clinical Nutrition, February 1, 2001; 73(2): 232 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Meiklejohn, M. A. Vickers, R. Dijkhuisen, and M. Greaves Plasma Homocysteine Concentrations in the Acute and Convalescent Periods of Atherothrombotic Stroke Stroke, January 1, 2001; 32(1): 57 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Chambers, H. Ireland, E. Thompson, P. Reilly, O. A. Obeid, H. Refsum, P. Ueland, D. A. Lane, and J. S. Kooner Methylenetetrahydrofolate Reductase 677 C->T Mutation and Coronary Heart Disease Risk in UK Indian Asians Arterioscler. Thromb. Vasc. Biol., November 1, 2000; 20(11): 2448 - 2452. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Diaz-Arrastia Homocysteine and Neurologic Disease Arch Neurol, October 1, 2000; 57(10): 1422 - 1427. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Watkins, J. D. Erickson, M. J. Thun, J. Mulinare, and C. W. Heath Jr. Multivitamin Use and Mortality in a Large Prospective Study Am. J. Epidemiol., July 15, 2000; 152(2): 149 - 162. [Full Text] [PDF] |
||||
![]() |
C. M. Ulrich, E. Kampman, J. Bigler, S. M. Schwartz, C. Chen, R. Bostick, L. Fosdick, S. A. A. Beresford, Y. Yasui, and J. D. Potter Lack of Association between the C677T MTHFR Polymorphism and Colorectal Hyperplastic Polyps Cancer Epidemiol. Biomarkers Prev., April 1, 2000; 9(4): 427 - 433. [Abstract] [Full Text] |
||||
![]() |
H. H. Yu, R. Joubran, M. Asmi, T. Law, A. Spencer, M. Jouma, and N. Rifai Agreement among Four Homocysteine Assays and Results in Patients with Coronary Atherosclerosis and Controls Clin. Chem., February 1, 2000; 46(2): 258 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mager, S. Lalezari, T. Shohat, Y. Birnbaum, Y. Adler, N. Magal, and M. Shohat Methylenetetrahydrofolate Reductase Genotypes and Early-Onset Coronary Artery Disease Circulation, December 14, 1999; 100(24): 2406 - 2410. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Fonseca, S. C. Guba, and L. M. Fink Hyperhomocysteinemia and the Endocrine System: Implications for Atherosclerosis and Thrombosis Endocr. Rev., October 1, 1999; 20(5): 738 - 759. [Abstract] [Full Text] |
||||
![]() |
E. B. Stamm and R. D. Reynolds Plasma Total Homocyst(e)ine May Not Be the Most Appropriate Index for Cardiovascular Disease Risk J. Nutr., October 1, 1999; 129(10): 1927 - 1930. [Full Text] |
||||
![]() |
J. Ma, M. J. Stampfer, B. Christensen, E. Giovannucci, D. J. Hunter, J. Chen, W. C. Willett, J. Selhub, C. H. Hennekens, R. Gravel, et al. A Polymorphism of the Methionine Synthase Gene: Association with Plasma Folate, Vitamin B12, Homocyst(e)ine, and Colorectal Cancer Risk Cancer Epidemiol. Biomarkers Prev., September 1, 1999; 8(9): 825 - 829. [Abstract] [Full Text] |
||||
![]() |
N Mahmud, A Molloy, J McPartlin, R Corbally, A S Whitehead, J M Scott, and D G Weir Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications Gut, September 1, 1999; 45(3): 389 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Ulrich, E. Kampman, J. Bigler, S. M. Schwartz, C. Chen, R. Bostick, L. Fosdick, S. A. A. Beresford, Y. Yasui, and J. D. Potter Colorectal Adenomas and the C677T MTHFR Polymorphism: Evidence for Gene-Environment Interaction? Cancer Epidemiol. Biomarkers Prev., August 1, 1999; 8(8): 659 - 668. [Abstract] [Full Text] |
||||
![]() |
M. Margaglione, G. D'Andrea, N. Giuliani, V. Brancaccio, D. De Lucia, E. Grandone, V. De Stefano, P. A. Tonali, and G. Di Minno Inherited Prothrombotic Conditions and Premature Ischemic Stroke : Sex Difference in the Association With Factor V Leiden Arterioscler. Thromb. Vasc. Biol., July 1, 1999; 19(7): 1751 - 1756. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gemmati, M. Previati, M. L. Serino, S. Moratelli, S. Guerra, S. Capitani, E. Forini, G. Ballerini, and G. L. Scapoli Low Folate Levels and Thermolabile Methylenetetrahydrofolate Reductase as Primary Determinant of Mild Hyperhomocystinemia in Normal and Thromboembolic Subjects Arterioscler. Thromb. Vasc. Biol., July 1, 1999; 19(7): 1761 - 1767. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Ridker, J. E. Manson, J. E. Buring, J. Shih, M. Matias, and C. H. Hennekens Homocysteine and Risk of Cardiovascular Disease Among Postmenopausal Women JAMA, May 19, 1999; 281(19): 1817 - 1821. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. de Jong, C. D. A. Stehouwer, M. van den Berg, P. J. Kostense, D. Alders, C. Jakobs, G. Pals, and J. A. Rauwerda Determinants of Fasting and Post-Methionine Homocysteine Levels in Families Predisposed to Hyperhomocysteinemia and Premature Vascular Disease Arterioscler. Thromb. Vasc. Biol., May 1, 1999; 19(5): 1316 - 1324. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Spence, M. R. Malinow, P. A. Barnett, A. J. Marian, D. Freeman, and R. A. Hegele Plasma Homocyst(e)ine Concentration, But Not MTHFR Genotype, Is Associated With Variation in Carotid Plaque Area Stroke, May 1, 1999; 30(5): 969 - 973. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Greenlund, S. R. Srinivasan, J.-H. Xu, E. Dalferes Jr, L. Myers, A. Pickoff, and G. S. Berenson Plasma Homocysteine Distribution and Its Association With Parental History of Coronary Artery Disease in Black and White Children : The Bogalusa Heart Study Circulation, April 27, 1999; 99(16): 2144 - 2149. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gardemann, H. Weidemann, M. Philipp, N. Katz, H. Tillmanns, F. W. Hehrlein, and W. Haberbosch The TT genotype of the methylenetetrahydrofolate reductase C677T gene polymorphism is associated with the extent of coronary atherosclerosis in patients at high risk for coronary artery disease Eur. Heart J., April 2, 1999; 20(8): 584 - 592. [Abstract] [PDF] |
||||
![]() |
D. L. Harmon, R. M. Doyle, R. Meleady, M. Doyle, D. C. Shields, R. Barry, D. Coakley, I. M. Graham, and A. S. Whitehead Genetic Analysis of the Thermolabile Variant of 5,10-Methylenetetrahydrofolate Reductase as a Risk Factor for Ischemic Stroke Arterioscler. Thromb. Vasc. Biol., February 1, 1999; 19(2): 208 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Morita, H. Kurihara, T. Sugiyama, C. Hamada, Y. Kurihara, T. Shindo, Y. Oh-hashi, and Y. Yazaki Polymorphism of the Methionine Synthase Gene : Association With Homocysteine Metabolism and Late-Onset Vascular Diseases in the Japanese Population Arterioscler. Thromb. Vasc. Biol., February 1, 1999; 19(2): 298 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, E. L. Giovannucci, and D. J. Hunter MTHFR Polymorphism, Methyl-Replete Diets and the Risk of Colorectal Carcinoma and Adenoma among U.S. Men and Women: An Example of Gene-Environment Interactions in Colorectal Tumorigenesis J. Nutr., February 1, 1999; 129(2): 560 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Malinow, A. G. Bostom, and R. M. Krauss Homocyst(e)ine, Diet, and Cardiovascular Diseases : A Statement for Healthcare Professionals From the Nutrition Committee, American Heart Association Circulation, January 12, 1999; 99(1): 178 - 182. [Full Text] [PDF] |
||||
![]() |
M. L. Bots, L. J. Launer, J. Lindemans, A. W. Hoes, A. Hofman, J. C. M. Witteman, P. J. Koudstaal, and D. E. Grobbee Homocysteine and Short-term Risk of Myocardial Infarction and Stroke in the Elderly: The Rotterdam Study Arch Intern Med, January 11, 1999; 159(1): 38 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Brattstrom, D. E. L. Wilcken, J. Ohrvik, and L. Brudin Common Methylenetetrahydrofolate Reductase Gene Mutation Leads to Hyperhomocysteinemia but Not to Vascular Disease : The Result of a Meta-Analysis Circulation, December 8, 1998; 98(23): 2520 - 2526. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Demuth, N. Moatti, O. Hanon, M. O. Benoit, M. Safar, and X. Girerd Opposite Effects of Plasma Homocysteine and the Methylenetetrahydrofolate Reductase C677T Mutation on Carotid Artery Geometry in Asymptomatic Adults Arterioscler. Thromb. Vasc. Biol., December 1, 1998; 18(12): 1838 - 1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Morita, H. Kurihara, S.-i. Tsubaki, T. Sugiyama, C. Hamada, Y. Kurihara, T. Shindo, Y. Oh-hashi, K. Kitamura, and Y. Yazaki Methylenetetrahydrofolate Reductase Gene Polymorphism and Ischemic Stroke in Japanese Arterioscler. Thromb. Vasc. Biol., September 1, 1998; 18(9): 1465 - 1469. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Verhoef, E. B. Rimm, D. J. Hunter, J. Chen, W. C. Willett, K. Kelsey, and M. J. Stampfer A common mutation in the methylenetetrahydrofolate reductase gene and risk of coronary heart disease: results among U.S. men J. Am. Coll. Cardiol., August 1, 1998; 32(2): 353 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Jacobsen Homocysteine and vitamins in cardiovascular disease Clin. Chem., August 1, 1998; 44(8): 1833 - 1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Folsom, F. J. Nieto, P. G. McGovern, M. Y. Tsai, M. R. Malinow, J. H. Eckfeldt, D. L. Hess, and C. E. Davis Prospective Study of Coronary Heart Disease Incidence in Relation to Fasting Total Homocysteine, Related Genetic Polymorphisms, and B Vitamins : The Atherosclerosis Risk in Communities (ARIC) Study Circulation, July 21, 1998; 98(3): 204 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Stein and P. E. McBride Hyperhomocysteinemia and Atherosclerotic Vascular Disease: Pathophysiology, Screening, and Treatment Arch Intern Med, June 22, 1998; 158(12): 1301 - 1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Girelli, S. Friso, E. Trabetti, O. Olivieri, C. Russo, R. Pessotto, G. Faccini, P. F. Pignatti, A. Mazzucco, and R. Corrocher Methylenetetrahydrofolate Reductase C677T Mutation, Plasma Homocysteine, and Folate in Subjects From Northern Italy With or Without Angiographically Documented Severe Coronary Atherosclerotic Disease: Evidence for an Important Genetic-Environmental Interaction Blood, June 1, 1998; 91(11): 4158 - 4163. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Wald, H. C. Watt, M. R. Law, D. G. Weir, J. McPartlin, and J. M. Scott Homocysteine and Ischemic Heart Disease: Results of a Prospective Study With Implications Regarding Prevention Arch Intern Med, April 27, 1998; 158(8): 862 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Welch and J. Loscalzo Homocysteine and Atherothrombosis N. Engl. J. Med., April 9, 1998; 338(15): 1042 - 1050. [Full Text] [PDF] |
||||
![]() |
L. Soriente, A. Coppola, P. Madonna, A. M. Cerbone, G. Di Minno, G. Orefice, A. D'Angelo, and H.S. Markus Homozygous C677T Mutation of the 5,10 Methylenetetrahydrofolate Reductase Gene and Hyperhomocysteinemia in Italian Patients With a History of Early-Onset Ischemic Stroke • Response Stroke, April 1, 1998; 29(4): 869 - 871. [Full Text] [PDF] |
||||
![]() |
C. H. Hennekens Increasing Burden of Cardiovascular Disease : Current Knowledge and Future Directions for Research on Risk Factors Circulation, March 24, 1998; 97(11): 1095 - 1102. [Full Text] [PDF] |
||||
![]() |
L. A. J. Kluijtmans, J. J. P. Kastelein, J. Lindemans, G. H. J. Boers, S. G. Heil, A. V. G. Bruschke, J. W. Jukema, L. P. W. J. van den Heuvel, F. J. M. Trijbels, G. J. M. Boerma, et al. Thermolabile Methylenetetrahydrofolate Reductase in Coronary Artery Disease Circulation, October 21, 1997; 96(8): 2573 - 2577. [Abstract] [Full Text] |
||||
![]() |
H. S. Markus, N. Ali, R. Swaminathan, A. Sankaralingam, J. Molloy, and J. Powell A Common Polymorphism in the Methylenetetrahydrofolate Reductase Gene, Homocysteine, and Ischemic Cerebrovascular Disease Stroke, September 1, 1997; 28(9): 1739 - 1743. [Abstract] [Full Text] |
||||
![]() |
S. M. Schwartz, D. S. Siscovick, M. R. Malinow, F. R. Rosendaal, R. K. Beverly, D. L. Hess, B. M. Psaty, W. T. Longstreth Jr, T. D. Koepsell, T. E. Raghunathan, et al. Myocardial Infarction in Young Women in Relation to Plasma Total Homocysteine, Folate, and a Common Variant in the Methylenetetrahydrofolate Reductase Gene Circulation, July 15, 1997; 96(2): 412 - 417. [Abstract] [Full Text] |
||||
![]() |
A. D'Angelo and J. Selhub Homocysteine and Thrombotic Disease Blood, July 1, 1997; 90(1): 1 - 11. [Full Text] [PDF] |
||||
![]() |
P. M. Ridker, C. H. Hennekens, J. Selhub, J. P. Miletich, M. R. Malinow, and M. J. Stampfer Interrelation of Hyperhomocyst(e)inemia, Factor V Leiden, and Risk of Future Venous Thromboembolism Circulation, April 1, 1997; 95(7): 1777 - 1782. [Abstract] [Full Text] |
||||
![]() |
J. L. Wiemels, R. N. Smith, G. M. Taylor, O. B. Eden, F. E. Alexander, M. F. Greaves, and United Kingdom Childhood Cancer Study Investigator Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia PNAS, March 27, 2001; 98(7): 4004 - 4009. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Friso, S.-W. Choi, D. Girelli, J. B. Mason, G. G. Dolnikowski, P. J. Bagley, O. Olivieri, P. F. Jacques, I. H. Rosenberg, R. Corrocher, et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status PNAS, April 16, 2002; 99(8): 5606 - 5611. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |